4//SEC Filing
JOHNSON JOHN 4
Accession 0001867096-25-000141
CIK 0001867096other
Filed
Aug 14, 8:00 PM ET
Accepted
Aug 15, 4:57 PM ET
Size
5.0 KB
Accession
0001867096-25-000141
Insider Transaction Report
Form 4
Johnson John H
Director
Transactions
- Sale
Common Stock
2025-08-13$7.32/sh−107,500$786,459→ 833,483 total
Footnotes (1)
- [F1]The price reported in is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.250 to $7.420, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
Documents
Issuer
Xeris Biopharma Holdings, Inc.
CIK 0001867096
Entity typeother
Related Parties
1- filerCIK 0001410781
Filing Metadata
- Form type
- 4
- Filed
- Aug 14, 8:00 PM ET
- Accepted
- Aug 15, 4:57 PM ET
- Size
- 5.0 KB